Peter L. Saltonstall, president and CEO of the National Organization for Rare Disorders (NORD), said the Food and Drug Administration's (FDA) announcement that it has created a new position Associate Director for Rare Diseases in the agency's Center for Drug Evaluation and Research's (CDER)...
Peter L. Saltonstall, president and CEO of the National Organization for Rare Disorders (NORD), said the Food and Drug Administration's (FDA) announcement that it has created a new position Associate Director for Rare Diseases in the agency's Center for Drug Evaluation and Research's (CDER)...